GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CellaVision AB (OTCPK:CLVSF) » Definitions » Forward Dividend Yield %

CLVSF (CellaVision AB) Forward Dividend Yield % : 0.00% (As of May. 06, 2025)


View and export this data going back to 2010. Start your Free Trial

What is CellaVision AB Forward Dividend Yield %?

As of today (2025-05-06), the Forward Annual Dividend Yield of CellaVision AB is 0.00%.

As of today (2025-05-06), the Trailing Annual Dividend Yield of CellaVision AB is 0.00%.

CLVSF's Forward Dividend Yield % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.05
* Ranked among companies with meaningful Forward Dividend Yield % only.

CellaVision AB's Dividends per Share for the three months ended in Mar. 2025 was $0.00.

During the past 3 years, the average Dividends Per Share Growth Rate was 44.20% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of CellaVision AB was 55.40% per year. The lowest was -20.60% per year. And the median was 35.70% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of CellaVision AB's Forward Dividend Yield %

For the Medical Devices subindustry, CellaVision AB's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CellaVision AB's Forward Dividend Yield % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, CellaVision AB's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where CellaVision AB's Forward Dividend Yield % falls into.


;
;

CellaVision AB Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.


CellaVision AB  (OTCPK:CLVSF) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


CellaVision AB Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of CellaVision AB's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


CellaVision AB Business Description

Traded in Other Exchanges
Address
Mobilvagen 12, Lund, SWE, 22362
CellaVision AB is engaged in the business of supplying digital solutions for blood and body fluid analysis. Its solutions are based on digital image analysis technology, artificial intelligence, and information technology. The firm's product portfolio consists of CellaVision peripheral blood application, CellaVision advanced RBC application, and CellaVision remote review software. Its customers include mainly large hospital laboratories and commercial laboratories in North America, Europe and China, and Japan. The company derives the majority of its revenue from the sale of analyzers or software.

CellaVision AB Headlines